In response to growing market volatility, an investor has shifted their portfolio toward defensive dividend stocks. They recently allocated $4,600 across three companies: Abbott Laboratories (NYSE: ABT), Procter & Gamble (NYSE: PG), and Paychex (NASDAQ: PAYX). This move comes amid warning signs, including high CAPE ratios, soaring margin debt, and persistent inflation, which led the Federal Reserve to raise interest rates for the first time in three years.
Abbott Laboratories stands out as a healthcare dividend stalwart, boasting 54 consecutive years of dividend increases. The company raised its payout by 6.8% last year and has grown its dividend by 70% since 2020. With a 2.4% dividend yield and a history of nearly 10% annual earnings growth, Abbott offers a compelling mix of stability and long-term potential. The investor purchased $1,000 worth of Abbott stock.
Procter & Gamble, another dividend powerhouse, has extended its dividend growth streak to 70 consecutive years, including a 4% raise in early 2026. Trading at its lowest valuation in years, P&G offers a nearly 2.8% dividend yield. The investor allocated over $2,000 to P&G, citing its resilient cash flows and long-term earnings growth prospects.
Paychex, a leading provider of HR solutions, rounds out the trio with a 4.3% dividend yield and a fifth consecutive double-digit dividend increase. The company has delivered strong revenue and earnings growth over the past five years, though it expects a slight slowdown this year. The investor invested nearly $1,600 in Paychex, attracted by its durable cash flow and growth potential.